Effectiveness of Pharmacist-Led Brief Educational Intervention for Adherence to the Antibiotics for Lower Respiratory Tract Infections (EATSA) in Post-Conflict Rural Areas of Pakistan: Study Protocol for a Randomized Controlled Trial.

LRTIS Pakistan antibiotic antibiotic resistance educational interventions pharmacists

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
23 Sep 2021
Historique:
received: 05 08 2021
revised: 10 09 2021
accepted: 17 09 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 24 10 2021
Statut: epublish

Résumé

Globally, lower respiratory infections (LRTIs) are one of the most common infectious diseases whichaffect majority of the population and as a result of inappropriate antibiotics practices lead to antibiotic resistance (AR). An individual randomized control trial will be conducted in the post-conflict areas of Swat, Pakistan, through a random sampling method. Patients aged > 18 years will be recruited from five community pharmacies and assigned to equally sized groups to receive either pharmacist-led education interventions or usual care with no intervention. A total of 400 (control = 200, study = 200) patients will be included, with prescriptions comprised of antibiotics for LRTIs. The outcomes measured in both groups will be a combination of treatment cure rate and adherence, which will be assessed using the Morisky Medication Adherence Scale and pill count. The trial comprises pharmacist-led educational interventions to improve treatment outcomes for patients with LRTIs. This study might establish the groundwork for pharmaceutical care of LRTIs patients with antibacterial therapy and the future delivery of a care strategy for the improvement of LRTIs treatment outcomes in post-conflict, remote areas of the third world and LMICs.

Identifiants

pubmed: 34680728
pii: antibiotics10101147
doi: 10.3390/antibiotics10101147
pmc: PMC8532944
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : This work was funded by the National Natural Science Fund (71974156), "Young Talent Support Plan", "High Achiever Plan" of Health Science Center, Xi'an Jiaotong University, and the Central University Basic Research Fund (2015qngz05).
ID : 71974156

Références

Int J Environ Res Public Health. 2021 Feb 01;18(3):
pubmed: 33535695
Thorax. 2012 Jan;67(1):71-9
pubmed: 20729232
Lancet. 2009 Jul 4;374(9683):23-4
pubmed: 19577684
Prim Care Respir J. 2011 Sep;20(3):299-306, 6 p following 306
pubmed: 21509421
Expert Rev Respir Med. 2019 Jan;13(1):63-77
pubmed: 30518278
Arch Dis Child. 2013 Feb;98(2):90-1
pubmed: 23235889
BMC Infect Dis. 2017 Sep 11;17(1):614
pubmed: 28893195
Eur J Investig Health Psychol Educ. 2021 Jan 19;11(1):71-82
pubmed: 34542450
J Infect Dis. 2008 Oct 1;198(7):962-70
pubmed: 18710327
Nephrol Dial Transplant. 2010 May;25(5):1388-93
pubmed: 20067907
Trials. 2017 Apr 26;18(1):190
pubmed: 28441974
MMWR Morb Mortal Wkly Rep. 2012 Nov 23;61(46):938-43
pubmed: 23169314
Respir Res. 2013 Oct 20;14:109
pubmed: 24138097
Lancet. 2019 Apr 27;393(10182):1733-1744
pubmed: 30948286
Int J Antimicrob Agents. 2011 Aug;38(2):108-17
pubmed: 21683553
Infect Drug Resist. 2021 Mar 22;14:1129-1140
pubmed: 33790584
Int J Environ Res Public Health. 2020 Mar 31;17(7):
pubmed: 32244475
N Engl J Med. 2020 Jul 2;383(1):24-34
pubmed: 32609980
Clin Microbiol Infect. 2011 Nov;17 Suppl 6:E1-59
pubmed: 21951385
J Coll Physicians Surg Pak. 2020 Aug;30(8):882-883
pubmed: 32893807
BMC Public Health. 2019 May 10;19(Suppl 3):498
pubmed: 32326918
BMJ. 2012 Sep 04;345:e5661
pubmed: 22951546
Med Care. 2006 Jul;44(7):617-28
pubmed: 16799356
Lancet Infect Dis. 2017 Nov;17(11):1133-1161
pubmed: 28843578
Infect Drug Resist. 2019 Mar 26;12:687-699
pubmed: 30988635
Ann Pharmacother. 2011 May;45(5):569-75
pubmed: 21521862
Res Social Adm Pharm. 2019 Feb;15(2):193-201
pubmed: 29685459
Lancet Infect Dis. 2018 Nov;18(11):1191-1210
pubmed: 30243584
Ann Pharmacother. 2004 Feb;38(2):303-12
pubmed: 14742770
Int J Infect Dis. 2010 Oct;14(10):e852-6
pubmed: 20615741
Postgrad Med. 2010 Mar;122(2):130-41
pubmed: 20203464
J Adv Pharm Technol Res. 2020 Jul-Sep;11(3):113-116
pubmed: 33102193
J Clin Hypertens (Greenwich). 2008 May;10(5):348-54
pubmed: 18453793
PLoS One. 2020 Apr 7;15(4):e0231188
pubmed: 32255809
JAMA. 2016 Sep 20;316(11):1193-1204
pubmed: 27654605
Chest. 2018 Nov;154(5):1202-1212
pubmed: 29959904
Expert Rev Anti Infect Ther. 2020 Sep;18(9):937-946
pubmed: 32516001
Pharm World Sci. 2006 Jun;28(3):165-70
pubmed: 17004019
Arch Dis Child. 2013 Feb;98(2):146-54
pubmed: 23142784
Epidemiol Psychiatr Sci. 2019 Feb;28(1):77-87
pubmed: 28689511

Auteurs

Faiz Ullah Khan (FU)

Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.
Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an 710061, China.
Shaanxi Center for Health Reform and Development Research, Xi'an 710061, China.
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, Western China Science & Technology Innovation Harbor, Xi'an 710061, China.

Yu Fang (Y)

Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.
Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an 710061, China.
Shaanxi Center for Health Reform and Development Research, Xi'an 710061, China.
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, Western China Science & Technology Innovation Harbor, Xi'an 710061, China.

Classifications MeSH